SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder
7 references·1 citing·29 second hop
Placebo-controlled trial of the CCK-B antagonist, CI-988, in panic disorder (1999)Placebo-controlled trial of the CCK-B ant…The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients (1997)The cholecystokinin-B recepto…Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks (1997)Effect of the selective serot…A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder (1995)A placebo-controlled trial of…A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder (1995)A Double-Blind, Placebo-Contr…The Cholecystokinin Hypothesis of Anxiety and Panic Disordera (1994)The Cholecystokinin Hypothesi…Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients (1994)Pentagastrin induced panic at…Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients (1994)Imipramine antagonism of the …Tratamento farmacológico do transtorno de ansiedade generalizada: perspectivas futuras (2001)Tratamento farmacológico do t…Genetic Factors in Anxiety Disorders (1983)Diagnostic and Statistical Manual of Mental Disorders (1988)Psychiatric disorders in America (1991)Genetic linkage study of panic: Clinical methodology and description of pedigrees (1999)Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study (2007)Functional neuroanatomy of CCK‐4‐induced panic attacks in healthy volunteers (2007)Assessment of fear of fear in agoraphobics: The Body Sensations Questionnaire and the Agoraphobic Cognitions Questionnaire. (1984)Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) (1987)Panic Disorder-A Malfunction of Multiple Transmitter Control Systems within the Midbrain Periaqueductal Gray Matter? (2000)Diagnostic and Statistical Manual of Mental Disorders (2013)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)ECDEU Assessment Manual for Psychopharmacology (1976)The psychobiology of anxiolytic drugs (2000)Generalised Anxiety Disorder (2002)Brief standard self-rating for phobic patients (1979)The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder (1996)Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients (2001)Long-term Treatment of Anxiety and Risk of Withdrawal (1988)Antidepressants for the Treatment of Generalized Anxiety Disorder (1993)Psychopharmacology: The Fourth Generation of Progress (1995)Development of a Rating Scale for Primary Depressive Illness (1967)Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder (2004)A RATING SCALE FOR DEPRESSION (1960)Reliability of Anxiety Assessment (1989)Reliability of DSM-III-R Anxiety Disorder Categories (1993)Novel treatment approaches for refractory anxiety disorders (2007)Contextual conditioning in rats as an animal model for generalized anxiety disorder (2011)Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine (2002)Selective GABAergic treatment for panic? Investigations in experimental panic induction and panic disorder (2005)
this work references cited by second hop

References

  • 1995A placebo-controlled trial of L-365,260, a CCKB antagonist, in panic disorder117 cited
  • 1994Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients109 cited
  • 1994The Cholecystokinin Hypothesis of Anxiety and Panic Disordera92 cited
  • 1994Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients90 cited
  • 1995A Double-Blind, Placebo-Controlled Study of a CCK-B Receptor Antagonist, CI-988, in Patients With Generalized Anxiety Disorder79 cited
  • 1997Effect of the selective serotonin reuptake inhibitor fluvoxamine on CCK-4 induced panic attacks79 cited
  • 1997The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients75 cited

Cited by

  • 2001Tratamento farmacológico do transtorno de ansiedade generalizada: perspectivas futuras53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work